---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-22-005083"
form_type: "8-K"
ticker: "SNOA"
cik: "0001367083"
company_name: "Sonoma Pharmaceuticals, Inc."
filed_at: "2022-07-22T23:59:59+00:00"
generated_at: "2026-06-24T09:30:01.502555+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Sonoma Pharmaceuticals appoints CEO to board, amends exec agreements, CFO to resign amid office consolidation

## Summary
- CEO Amy Trombly appointed to board effective July 22, 2022; amended employment agreement with severance of one-time base salary.
- COO Bruce Thornton agreement amended; change-in-control bonus of 50% of base salary added.
- CFO Jerry Dvonch resigns effective on/before Dec 31, 2022; severance of $100,000 plus COBRA and equity acceleration.
- Annual bonus grants approved: $162,500 for Trombly, $150,000 for Thornton.
- Company consolidating to Boulder, CO; closing Woodstock, GA office as part of cost-cutting.

## SEC filing metadata
- accession: 0001683168-22-005083
- form_type: 8-K
- ticker: SNOA
- cik: 0001367083
- company_name: Sonoma Pharmaceuticals, Inc.
- filed_at: 2022-07-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367083/000168316822005083/0001683168-22-005083-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367083/000168316822005083/snoa_i8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-22-005083
- JSON: https://secwatch.observer/filing/0001683168-22-005083.json
- Plain text: https://secwatch.observer/filing/0001683168-22-005083.txt

## Key facts
- Executive change
  Jerry Dvonch resigned as Chief Financial Officer at Sonoma Pharmaceuticals, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: In connection with the Woodstock office closure, Mr. Jerry Dvonch resigned as our Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1367083/000168316822005083/0001683168-22-005083-index.htm
- Executive change
  Amy Trombly was appointed as Director at Sonoma Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Director
  source text: Effective July 22, 2022, the Company’s Board of Directors appointed Amy Trombly, our Chief Executive Officer, to serve as a member of our Board of Directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1367083/000168316822005083/0001683168-22-005083-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.